uric acid has been researched along with isoxazoles in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, T; Koga, H; Onuma, E; Tanaka, H | 1 |
| Dan, T; Koga, H | 1 |
| Dan, T; Koga, H; Tanaka, H | 1 |
| Aoki, B; Dan, T; Koga, H; Onuma, E; Sato, H; Tanaka, H | 1 |
| Dan, T; Onoma, M; Onuma, E; Ozawa, K; Yoneya, T | 1 |
| Joo, HJ; Kim, KA; Park, JY | 1 |
| Dhaun, N; Goddard, J; Johnston, NR; Webb, DJ | 1 |
| Arida, D; Silva, L; Skare, TL | 1 |
| Benza, RL; Dhaun, N; Hwang, LJ; Liu, X; Naeije, R; Teal, S; Vachiery, JL; Webb, DJ | 1 |
| Choe, JY; Kim, SK | 1 |
| Cai, GY; Chen, XM; Duan, SW; Huang, W; Jia, Q; Li, JJ; Li, WG; Li, XM; Liu, SW; Liu, WH; Lun, LD; Ma, L; Sun, XF; Wang, YP; Wu, H; Wu, J; Xie, YS; Zhang, JR; Zhou, CH | 1 |
| Alfieri, DF; Costa, NT; de Medeiros, FA; de Sá, MC; Dichi, I; Iriyoda, TMV; Lozovoy, MAB; Maes, M; Micheletti, PL; Reiche, EMV; Scavuzzi, BM; Sekiguchi, BA; Simão, ANC | 1 |
3 trial(s) available for uric acid and isoxazoles
| Article | Year |
|---|---|
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperuricemia; Isoxazoles; Kidney Failure, Chronic; Thiophenes; Treatment Outcome; Uric Acid | 2011 |
Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bosentan; Child; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Prospective Studies; Sulfonamides; Survival Rate; Thiophenes; Time Factors; Treatment Outcome; United States; Uric Acid; Young Adult | 2014 |
Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.
Topics: Adolescent; Adult; Benzimidazoles; Benzoates; Blood Pressure; China; Clopidogrel; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Isoxazoles; Kidney Function Tests; Leflunomide; Male; Middle Aged; Prospective Studies; Telmisartan; Ticlopidine; Treatment Outcome; Uric Acid; Young Adult | 2016 |
9 other study(ies) available for uric acid and isoxazoles
| Article | Year |
|---|---|
A selective uricosuric action of AA-193 in rats. Comparison with its effect on PAH secretion in vivo and in vitro.
Topics: Animals; In Vitro Techniques; Isoxazoles; Kidney; Male; Microvilli; p-Aminohippuric Acid; Rats; Rats, Inbred Strains; Renal Circulation; Ticrynafen; Uric Acid; Uricosuric Agents | 1991 |
Uricosurics inhibit urate transporter in rat renal brush border membrane vesicles.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Hydroxides; In Vitro Techniques; Intracellular Membranes; Ion Exchange; Isoxazoles; Kidney; Kinetics; Male; Microvilli; Rats; Rats, Inbred Strains; Uric Acid; Uricosuric Agents | 1990 |
Mechanism of uricosuric action of AA-193 in DBA/2N mice.
Topics: Animals; Inulin; Isoxazoles; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Oxazoles; Pyrazinamide; Species Specificity; Uric Acid; Uricosuric Agents | 1990 |
The activity of AA-193, a new uricosuric agent, in animals.
Topics: Animals; Cebus; Dose-Response Relationship, Drug; Gout Suppressants; Isoxazoles; Male; Metabolic Clearance Rate; Mice; Pyrazinamide; Rats; Rats, Inbred Strains; Species Specificity; Uric Acid; Uricosuric Agents; Urinary Bladder | 1989 |
Hypouricemic and uricosuric actions of AA-193 in a hyperuricemic rat model.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Isoxazoles; Kidney; Liver; Male; Oxonic Acid; Rats; Rats, Wistar; Time Factors; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Dehydrogenase | 1994 |
Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level.
Topics: Aniline Compounds; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Crotonates; Genotype; Humans; Hydroxybutyrates; Isoxazoles; Leflunomide; Neoplasm Proteins; Nitriles; Polymorphism, Single Nucleotide; Prodrugs; Protein Transport; Toluidines; Uric Acid | 2011 |
The hypouricemiant effect of leflunomide.
Topics: Adult; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Uric Acid | 2014 |
Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide.
Topics: Aged; Arthritis, Rheumatoid; Female; Glomerular Filtration Rate; Humans; Inflammation; Isoxazoles; Leflunomide; Male; Middle Aged; Uric Acid | 2015 |
Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Advanced Oxidation Protein Products; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Case-Control Studies; Disease Progression; Female; Gene Expression; Humans; Isoxazoles; Leflunomide; Lipid Peroxides; Male; Metabolic Syndrome; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Sex Factors; Uric Acid | 2018 |